We now support RECIST (Response Evaluation Criteria in Solid Tumors) studies. This milestone empowers sponsors and CROs to leverage our industry-leading imaging and data management solutions for standardized tumor response assessments—delivering accuracy, efficiency, and confidence at every step.
Standardized, Protocol-Driven Assessments
Deliver consistent, RECIST-aligned evaluations to keep oncology trials compliant and reliable.
Streamlined Workflows for Accuracy and Speed
Enhanced processes for lesion tracking and endpoint calculations simplify complex tasks and help accelerate timelines.
Smarter Adjudication Support
Rules-based triggers and clear workflows give adjudicators better visibility into findings, improving efficiency and decision-making.
Advanced Lesion Management
Handle complex scenarios like lesion splits, merges, and morphologic changes with precision—maintaining consistency across reads.
Stay Aligned, Stay Ready
Built-in logic supports RECIST guidelines and audit readiness, giving you confidence in your submissions.
Focus Where It Counts
Improved workflows and robust data capture help keep your studies on track and your teams focused.
This is more than an upgrade—it’s progress toward smarter, more streamlined oncology imaging. And we’re just getting started.
Additional Information
Category: New feature
Product: NxT
Version: 8.0
Release Date: December 21, 2025
Impact: Medical Imaging
